from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1727/-

LFCtreatmentdescriptionclass of inhibitor

0.003

Amikacinug/mL Amikacintranslation

-0.144

Cap5-10ug/mL Capreomycintranslation

1.108

Rox10-50 ug/mL Roxithromycintranslation

0.185

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.194

Rif0.2-5ug/mL Rifampicintranscription

0.692

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.399

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.558

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.657

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.219

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.380

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.315

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.013

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

4.808

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.640

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.254

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.021

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.678

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.155

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.554

KCN5-20 ug/mL Potassium cyaniderespiration

-0.163

NaN30.2-2 mM Sodium aziderespiration

0.537

Nigericin50 uM Nigericinrespiration

0.900

TRC10-150 ug/mL Triclosanrespiration

0.850

TRZ10-25 ug/mL Thioridazinerespiration

-0.429

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.433

menadione6-10 ug/mL Menadionerespiration

0.005

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.440

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.414

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.239

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.316

NRP_1Non-replicating persistence stage 1dosRassociated

1.615

Amp0.2mg/mL AmpicillincellWall

-0.035

Cephalexin20-100 ug/mL CephalexincellWall

0.500

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.349

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.120

EMB10-20 ug/mL EthambutolcellWall

0.068

Eta12-40 ug/mL EthionamidecellWall

0.268

INH0.2-0.4 ug/mL IsoniazidcellWall

0.201

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.570

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.501

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.333

BZA0.12 mg/mL BenzamidearomaticAmides

-0.626

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.065

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.277

H2O24 mM hydrogen peroxideDNAdamaging

0.034

Levo10 ug/mL LevofloxacinDNAdamaging

-0.363

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.386

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.141

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.672

UVUV-irradiationDNAdamaging

0.999

ARP41-4 ug/mL Antitubercular compound ARP4?

0.543

Antimycin12.5-50 ug/mL Antimycin A?

0.228

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.826

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.184

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.429

PA8240.2-2 ug/mL PA-824?

-0.371

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.298

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.377

Verapamil50 uM Verapamil?

1.099

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.019

methoxatin10-20 ug/mL Methoxatin?